[1]
Nesen, A., Savicheva, K., Semenovykh, P. and Galchiskaya, V. 2022. Vasopressin marker copeptin and the development of renal and metabolic disorders in patients with type 2 diabetes. Ukrainian Journal of Nephrology and Dialysis. 3(75) (Jun. 2022), 55-62. DOI:https://doi.org/10.31450/ukrjnd.3(75).2022.07.